Compounds > pentacyanoferrate (ii)
Page last updated: 2024-09-04

pentacyanoferrate (ii) and isoniazid

pentacyanoferrate (ii) has been researched along with isoniazid in 2 studies

Compound Research Comparison

Studies
(pentacyanoferrate (ii))		Trials
(pentacyanoferrate (ii))		Recent Studies (post-2010)
(pentacyanoferrate (ii))		Studies
(isoniazid)		Trials
(isoniazid)		Recent Studies (post-2010) (isoniazid)
110521,8159604,493

Protein Interaction Comparison

ProteinTaxonomypentacyanoferrate (ii) (IC50)isoniazid (IC50)
MyeloperoxidaseHomo sapiens (human)4.85
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv8.29
Putative FAD-containing monooxygenase MymAMycobacterium tuberculosis H37Rv4.9

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
da Costa, AL; de Souza, ON; Dorn, M; Pauli, I; Schroeder, EK; Zhan, CG1
Basso, LA; Calixto, JB; Campos, MM; de França Lopes, LG; Dos Santos Junior, A; Dos Santos, AJ; Rodrigues-Junior, VS; Santos, DS; Schneider, CZ; Sousa, EH; Souto, AA1

Other Studies

2 other study(ies) available for pentacyanoferrate (ii) and isoniazid

ArticleYear
Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
    Journal of molecular modeling, 2012, Volume: 18, Issue:5

    Topics: Antitubercular Agents; Bacterial Proteins; Catalase; Catalytic Domain; Drug Design; Ferrous Compounds; Isoniazid; Kinetics; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; Protein Conformation

2012
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:2

    Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis

2012